FAP syndrome
Familial adenomatous polyposis (FAP) is an inherited disorder sometimes found in people with colorectal cancer.
People with FAP may develop noncancerous (benign) colon polyps as early as their teenage years.
What is FAP: the facts
- Familial adenomatous polyposis (FAP) is an inherited disorder sometimes found in people with colorectal cancer.
- Approximately two percent of all colon cancer could be caused by a hereditary adenomatous polyposis condition.
- People with the classic type of FAP may develop noncancerous (benign) colon polyps as early as their teenage years.
- Screening usually begins at eight to ten years old.
- The type of polyp most often seen in FAP syndrome, called an adenoma, is precancerous.
- The average age at which an individual with FAP develops colorectal cancer is 39 years old.
- Some people have a variation of the disorder, called attenuated familial adenomatous polyposis (AFAP), with fewer polyps.
- The average age of colon cancer onset for those with AFAP is 55 years.
- People with FAP can also develop noncancerous growths called desmoid tumors which are noncancerous (benign) tumors that typically develop in the arms, legs, abdomen.
![woman in lab in white coat](/sites/default/files/styles/fifty_fifty/public/media/images/woman_in_lab_in_white_coat.jpeg.webp?itok=W8ch-_5t)
Other tumors in the body
In both classic FAP and AFAP, benign and cancerous tumors are sometimes found in other places in the body, including the small intestine, stomach, bones, skin, and other tissues. People who have colon polyps outside the colon are sometimes described as having Gardner syndrome.
FAP: Causes, risks, prediction, and screening
![family in keep calm shirts](/sites/default/files/styles/fifty_fifty/public/media/images/family_in_keep_calm_shirts_2.jpeg.jpg.webp?itok=0a_IKPDT)
Genetics and your risk of colon cancer
About five to seven percent of colon cancer patients have inherited a gene mutation that puts them at higher risk of developing colorectal cancer. Knowing your family history is an important part of prevention.
![multi generational family](/sites/default/files/styles/fifty_fifty/public/media/images/multi_generational_family.jpg.webp?h=7be9432b&itok=aZE7SLHZ)
Blog: Are you at high risk for colon cancer?
Having any inherited risk factors on your radar early will allow you to be your own advocate and be proactive about your health and screenings. Learn about what you can and cannot control in terms of risk, such as diet, age, lifestyle, and ethnicity.
We are here for you
Facing FAP syndrome or other inherited risks can make you feel isolated. Find allies in our online communities, our Buddy Program, one-on-one support from our live navigators, and much more. You are not alone.
Other inherited conditions
Muir-Torre syndromeTop resources
![A sign at the BMS headquarters](/sites/default/files/styles/450x250/public/media/images/bms-sign-1920.png.webp?itok=qtRzhXHJ)
Krazati approved for previously treated KRASG12C colorectal cancer
The treatment option is for patients with KRASG12C-mutated locally advanced or metastatic colorectal cancer (CRC) who have received prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.
![The city of Philadelphia](/sites/default/files/styles/450x250/public/media/images/philadelphia.png.webp?itok=CyT8nkqx)
Alliance adds partners to expand 45+ Reasons campaign
The Alliance’s 45+ Reasons campaign is part of the Cycles of Impact initiative launched and supported by Independence Blue Cross in 2022 to address the urgent public health issue of colorectal cancer among the Black population.
![Pillars in front of a court building](/sites/default/files/styles/450x250/public/media/images/court-pillars_0.png.webp?itok=vjw6DOGa)
Appeals Court decision protects access to no-cost preventive CRC screening
The U.S. Court of Appeals for the Fifth Circuit reversed a district court decision that had ruled provisions in the Affordable Care Act (ACA), which provide for no-cost preventive screening for colorectal cancer and other conditions, unconstitutional.